Beyond Air

Beyond Air Inc. is a clinical-stage medical device and biopharmaceutical company developing revolutionary nitric oxide (NO) generators and delivery systems that use ambient air to produce NO, delivering precise amounts of NO to the lungs for the treatment of respiratory diseases and other conditions.Beyond Air's NO delivery system can generate up to 400ppm of NO either continuously or over fixed periods and is capable of maintaining a constant dose through titration as needed. In addition to treating lower respiratory tract infections where current standard-of-care treatments have proven ineffective, the company is currently leveraging its therapeutic expertise to develop treatments for pulmonary hypertension in various settings. Beyond Air’s NO delivery system is used for treating neonatal pulmonary hypertension, bronchiolitis, and nontuberculous mycobacteria.The company’s lead development product is AirNOvent. AirNOvent is a ventilator-compatible NO generator and delivery system, a cylinder-free, phase-flow nitric oxide delivery system, which has been designated by the U.S. Food and Drug Administration (FDA) as a medical device. The device can generate NO on demand and deliver it to the lungs at concentrations ranging from 1 part per million (ppm) to 80ppm. A significant advantage of this device in hospital settings is the elimination of the need for large high-pressure cylinders of NO.AIT Therapeutics changed its name to Beyond Air™ on June 26, 2019.